K242304

Substantially Equivalent

RED

Applicant: Neuraxis, Inc.
Product code: KLA
Advisory panel: Gastroenterology, Urology
Date received: 2024-08-05
Decision date: 2024-12-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Carmel, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.